Back
Sarepta Therapeutics Stock Price Chart
20 High-Yield Dividend Stocks that Could Ruin Your Retirement
Sign up now to get this report and avoid a high-yield dividend trap - Yours FREE.
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
151.67
Seasonality Move:
21.71%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Own Before the 2024 Election
Click the link below to get your copy. FREE- The current trend is moderately bullish and SRPT is experiencing slight selling pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 155.81 | Sell |
| 20-day SMA: | 139.08 | Buy |
| 50-day SMA: | 132.55 | Buy |
| 200-day SMA: | 116.53 | Buy |
| 8-day EMA: | 152.29 | Sell |
| 20-day EMA: | 143.85 | Buy |
| 50-day EMA: | 134.87 | Buy |
| 200-day EMA: | 122.68 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.22 | Buy |
| Relative Strength Index (14 RSI): | 61.51 | Buy |
| Chaikin Money Flow: | -40120 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.42 - 153.54) | Buy |
| Bollinger Bands (100): | (118.38 - 140.08) | Buy |
Sarepta Therapeutics Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 151.73 while SRPT 8-day simple moving average is 155.81, which is a Sell signal.
- The stock price of SRPT is 151.73 while Sarepta Therapeutics 20-day SMA is 139.08, which makes it a Buy.
- Sarepta Therapeutics 50-day simple moving average is 132.55 while SRPT share price is 151.73, making it a Buy technically.
- SRPT stock price is 151.73 and Sarepta Therapeutics 200-day simple moving average is 116.53, creating a Buy signal.
SRPT Technical Analysis vs Fundamental Analysis
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Buy
The current Sarepta Therapeutics [SRPT] share price is $151.73. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
14.34B
Price in USD:
151.73
Share Volume:
641.93K
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
55.25
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 151.73 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is not overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 151.73 while SRPT 8-day exponential moving average is 152.29, which is a Sell signal.
- The stock price of SRPT is 151.73 while Sarepta Therapeutics 20-day EMA is 143.85, which makes it a Buy.
- Sarepta Therapeutics 50-day exponential moving average is 134.87 while SRPT share price is 151.73, making it a Buy technically.
- SRPT stock price is 151.73 and Sarepta Therapeutics 200-day simple moving average is 122.68, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is 8.22, suggesting Sarepta Therapeutics is a Buy
- Sarepta Therapeutics Relative Strength Index (RSI) is 61.51, which suggest Sarepta Therapeutics is overbought
- The Bollinger Bands (25) for Sarepta Therapeutics is (118.42 - 153.54), which suggest Sarepta Therapeutics is a Buy
- The Bollinger Bands (100) for Sarepta Therapeutics is (118.38 - 140.08), which suggest Sarepta Therapeutics is a Buy
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.